What underlies the observed hospital volume-outcome relationship? by Marius Huguet, Xavier Joutard, Isabelle Ray-Coquard, Lionel Perrier

Get full text

Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? by Ana Oaknin, Isabelle Ray-Coquard, Domenica Lorusso, Susana Banerjee

Get full text

Territory as cancers inequalities generator by Yohan Fayet, Virginie Chasles, Françoise Ducimetière, Pr Isabelle Ray-Coquard

Get full text

Le territoire, générateur d’inégalités face aux cancers by Yohan Fayet, Virginie Chasles, Françoise Ducimetière, Pr Isabelle Ray-Coquard

Get full text

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready? by Isabelle Ray-Coquard, Hélène Vanacker, Olivia Le Saux, Olivier Tredan

Get full text

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines? by Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, Christophe Caux

Get full text

BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges by Laetitia Collet, Laetitia Collet, Laetitia Collet, Brunhilde Hanvic, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Olivia Le Saux, Isabelle Ray-Coquard, Isabelle Ray-Coquard

Get full text

Cancer screening and follow-up in general practice: A French nationwide cross-sectional study by Marion Lamort-Bouché, Marine Chardon, Nadir Kellou, Isabelle Ray-Coquard, Cyrille Colin, Laurent Letrilliart

Get full text

The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways by Michael J. Birrer, Keiichi Fujiwara, Ana Oaknin, Leslie Randall, Laureen S. Ojalvo, Christian Valencia, Isabelle Ray-Coquard

Get full text

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion by Philipp Harter, Ana Oaknin, Isabelle Ray-Coquard, Domenica Lorusso, Kathleen N Moore, Antonio Gonzalez-Martin, Susana Banerjee

Get full text

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial by Michel Fabbro, Pierre-Jean Lamy, Pierre-Jean Lamy, Célia Touraine, Anne Floquet, Isabelle Ray-Coquard, Caroline Mollevi

Get full text

Expanding the molecular spectrum of tenosynovial giant cell tumors by Thibault Gauduchon, Helene Vanacker, Helene Vanacker, Daniel Pissaloux, Philippe Cassier, Armelle Dufresne, Marie Karanian, Alexandra Meurgey, Amine Bouhamama, François Gouin, Isabelle Ray-Coquard, Isabelle Ray-Coquard, Jean-Yves Blay, Jean-Yves Blay, Franck Tirode, Mehdi Brahmi, Mehdi Brahmi

Get full text

Correction to: Beyond the map: evidencing the spatial dimension of health inequalities by Yohan Fayet, Delphine Praud, Béatrice Fervers, Isabelle Ray-Coquard, Jean-Yves Blay, Françoise Ducimetiere, Guy Fagherazzi, Elodie Faure

Get full text

Development and validation of a bedside score to predict early death in cancer of unknown primary patients. by Nicolas Penel, Sylvie Negrier, Isabelle Ray-Coquard, Charles Ferte, Patrick Devos, Antoine Hollebecque, Michael B Sawyer, Antoine Adenis, Pascal Seve

Get full text

Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia. by Gerald A Soff, Isabelle Ray-Coquard, Luis J Marfil Rivera, Jon Fryzek, Megan Mullins, Lauren C Bylsma, Joseph K Park

Get full text

267 Pseudoprogression patterns: Analysis from 2 independent phase-2 studies with immunotherapy for recurrent cervical cancer by Isabelle Ray-Coquard, Jerome Alexandre, Waldo Ortuzar Feliu, Remigiusz Kaleta, David O’Malley, Michael O’Neal, Julie Cole, Robert Ludwig, Madhavi Nallewar, Victoria Borisovskaya

The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST by Loic Verlingue, Marine Desevre, Marie Polito, Gwenaelle Garin, Christine Rodriguez, Wang Qing, Olivier Tredan, David Perol, Isabelle Ray-Coquard, Sylvie Chabaud, Jean Yves Blay

Get full text

Very long‐term survivors among patients with metastatic soft tissue sarcoma by Mélodie Carbonnaux, Mehdi Brahmi, Camille Schiffler, Pierre Meeus, Marie‐Pierre Sunyach, Amine Bouhamama, Marie Karanian, Franck Tirode, Daniel Pissaloux, Gualter Vaz, Isabelle Ray‐Coquard, Jean‐Yves Blay, Armelle Dufresne

Get full text

Incidence and time trends of sarcoma (2000–2013): results from the French network of cancer registries (FRANCIM) by Brice Amadeo, Nicolas Penel, Jean-Michel Coindre, Isabelle Ray-Coquard, Karine Ligier, Patricia Delafosse, Anne-Marie Bouvier, Sandrine Plouvier, Justine Gallet, Aude Lacourt, Gaëlle Coureau, Alain Monnereau, Simone Mathoulin-Pélissier, Emmanuel Desandes

Get full text

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarco... by Lionel Perrier, Pauline Rascle, Magali Morelle, Maud Toulmonde, Dominique Ranchere Vince, Axel Le Cesne, Philippe Terrier, Agnès Neuville, Pierre Meeus, Fadila Farsi, Françoise Ducimetière, Jean-Yves Blay, Isabelle Ray Coquard, Jean-Michel Coindre

Get full text